Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition influenced by both genetic and environmental factors. In recent decades, nutrition has attracted growing interest as a potential modifier of autism risk and symptom severity. Researchers have examined maternal nutrition during pregnancy, micronutrient supplementation in children, and the role of gastrointestinal (GI) health and the gut microbiota. While no single dietary approach provides a cure, the scientific literature highlights several important connections between nutrition and autism.
Omega-3 Fatty Acids:
Omega-3 fatty acids, particularly docosahexaenoic acid (DHA), are critical for brain development and function. Several trials have investigated their role in autism. Voigt et al. (2014) conducted a randomized controlled trial supplementing children with ASD with 200 mg of DHA per day for six months. Despite significant increases in blood DHA levels, there were no consistent improvements in autism’s core symptoms compared with placebo. These results suggest that while DHA contributes to general brain health, supplementation alone may not directly alter autism symptomatology.
Vitamin D and Other Micronutrients
Vitamin D deficiency is common in children with ASD and has been linked to behavioral difficulties. Some clinical trials report modest improvements in irritability and hyperactivity with supplementation, though findings remain inconsistent across studies. Stewart et al. (2015) provided a broader perspective by examining dietary records of nearly 300 children with ASD. They found that while many families use multivitamin supplements, deficiencies in vitamin D and calcium often persist, and supplementation sometimes leads to excessive intake of nutrients such as vitamin A and zinc. This highlights the need for personalized nutritional monitoring rather than indiscriminate supplement use.
Folate and Folinic Acid
Perhaps the most consistent nutritional evidence concerns folate. Maternal folate intake during pregnancy appears protective against autism risk in offspring. Krakowiak et al. (2012) demonstrated that maternal metabolic conditions and nutritional factors influence developmental outcomes, while Surén et al. (2013) showed that adequate folate supplementation during pregnancy reduced autism risk. Beyond prevention, folinic acid supplementation in children with ASD has shown promising results in improving verbal communication and adaptive behaviors (Panda et al., 2024). However, other research warns of a U-shaped relationship, where both very low and very high folate levels may be problematic (Raghavan et al., 2018).
Zinc and Copper Balance
Trace minerals have also been implicated in autism. Feng et al. (2023) reported that children with ASD often present with elevated copper levels and lower zinc-to-copper ratios, patterns that correlate with greater symptom severity. While these findings are intriguing, they remain correlational and do not yet provide a clear pathway for clinical treatment.
Gut Microbiota and Gastrointestinal Health
One of the most active research areas involves the gut-brain connection. Gastrointestinal problems are significantly more common among children with autism than in typically developing peers. Adams et al. (2011) found that children with more severe autism also experienced more severe GI symptoms, suggesting a potential feedback loop between gut health and behavioral expression.
Interventions targeting the microbiota have gained momentum. Prebiotic studies, such as Grimaldi et al. (2018), reported that supplementation with galactooligosaccharides not only altered gut bacterial populations but also modestly improved social behaviors. Probiotic interventions similarly show potential for reducing GI discomfort, though effects on autism’s core features are inconsistent.
Perhaps the most promising approach is fecal microbiota transplantation (FMT). Li et al. (2021) demonstrated that children receiving FMT experienced significant improvements in both gastrointestinal symptoms and autism behaviors. Importantly, their gut bacterial composition shifted closer to that of typically developing controls. Although preliminary and requiring long-term safety data, such findings underline the strong connection between gut microbiota and autism symptoms.
Maternal Nutrition and Dietary Exposures
Maternal diet during pregnancy plays a crucial role in neurodevelopment. Beyond folate, dietary patterns rich in essential nutrients have been associated with healthier developmental outcomes. Peretti et al. (2019) reviewed evidence suggesting that maternal diet quality may influence autism risk. Similarly, studies on acetaminophen exposure during pregnancy indicate possible associations with autism, though causality remains uncertain (Liew et al., 2016). Collectively, these findings stress the importance of adequate and balanced maternal nutrition during critical windows of fetal brain development.
Conclusion
Nutrition does not offer a simple solution for autism, but it clearly interacts with both risk and symptom expression. The strongest evidence points to maternal folate intake as a protective factor, the persistent role of vitamin D and calcium deficiencies in children with ASD, and the significance of gastrointestinal health and microbiota composition. While omega-3 fatty acids and other supplements have shown mixed results, emerging interventions such as prebiotics, probiotics, and fecal microbiota transplantation highlight promising new directions. For families, this means nutritional strategies should not replace established therapies but may serve as supportive measures when carefully monitored by clinicians.
Table: Evidence Matrix (Nutrition ⇄ Autism)
| Topic / Exposure | Typical population & design | Main outcomes assessed | Direction of effect on outcomes | Overall certainty* | Representative studies (APA) |
|---|---|---|---|---|---|
| Prenatal multivitamins & folate/B12 (dose & blood levels) | Prospective birth cohorts; case–control | Child ASD diagnosis; risk by maternal intake/biomarkers | Moderate use of prenatal multivitamins/folate appears protective; very high maternal folate and B12 levels at delivery linked to higher risk; some cohorts show null associations. | Low–Moderate (observational, mixed) | Raghavan et al., 2018; Surén et al., 2013; Brieger et al., 2022; Gogou & Kolios, 2020 |
| Vitamin D for children with ASD | RCTs; meta-analyses; observational | Core ASD scales (SRS, CARS), irritability/hyperactivity (ABC), 25(OH)D | Mixed: some RCTs/meta suggest small improvements (esp. irritability/hyperactivity); other RCTs no primary benefit; responses may depend on baseline inflammation. | Low–Moderate | Song et al., 2020; Kerley et al., 2017; Mazahery et al., 2019a; Mazahery et al., 2020; Kittana et al., 2022 |
| Omega-3 (DHA/EPA) for children | RCTs; pilot trials | Core ASD & behavior (ABC, BASC, CGI-I) | Inconsistent/mostly null for core symptoms; small signals in subscales in some small trials. | Low | Voigt et al., 2014; Amminger et al., 2007 |
| Combined Vitamin D + Omega-3 | 12-month factorial RCT | SRS/SPM domains; irritability/hyperactivity | Modest improvements (e.g., irritability, social awareness); greater benefit in children with elevated IL-1β. | Low–Moderate | Mazahery et al., 2019a; Mazahery et al., 2020 |
| Folinic acid (leucovorin) add-on | Double-blind RCT | CARS; CBCL; folate receptor auto-antibodies | Improved ASD severity and behavior; larger gains in high FR-autoantibody subgroup; well-tolerated. | Moderate | Panda et al., 2024 |
| Vitamin A (retinol) status & supplementation | Observational; pilot interventions | Serum retinol; CARS/SRS/ABC; 5-HT; gut microbiota | ASD children often lower VA; supplementation improved symptoms & lowered 5-HT in one pilot; microbiome shifts seen; symptom change not consistent across studies; GI comorbidity worse with VA deficiency. | Low | Yang et al., 2022; Cheng et al., 2021; Guo et al., 2018; Liu et al., 2017 |
| Multi-vitamin/mineral supplements (child) | RCT; single-blind comprehensive program; survey | Parent-rated global change; IQ; metabolic markers | Metabolic profiles improved; parent-rated behavior and IQ improved in multi-component program; evidence for core symptoms limited/heterogeneous. | Low–Moderate | Adams et al., 2011; Adams et al., 2018; Adams et al., 2022 |
| B-vitamins + magnesium | Before–after (no control) | Urinary dicarboxylic acids (energy metabolism) | Biomarkers improved; clini |
* Certainty bands are pragmatic (not a formal GRADE): randomized/consistent = higher; observational/mixed/small samples = lower.
Plain-English Notes & Glossary
- ASD: Autism spectrum disorder.
- Core ASD scales: SRS (Social Responsiveness Scale), CARS (Childhood Autism Rating Scale), ABC (Aberrant Behavior Checklist), ATEC (Autism Treatment Evaluation Checklist). Lower scores typically mean improvement.
- CBCL: Child Behavior Checklist (behavior/emotion problems).
- 25(OH)D: Blood marker for vitamin-D status.
- DHA/EPA: Long-chain omega-3 fats commonly found in fish oil.
- Folate vs. folinic acid: Folate is vitamin B9 (including folic acid, the synthetic form). Folinic acid (leucovorin) is an active folate form used therapeutically; benefit may be larger when folate receptor auto-antibodies are present.
- Probiotic / Prebiotic: Probiotics are live microbes taken to benefit gut health; prebiotics (e.g., galacto-oligosaccharides) are fibers that feed beneficial bacteria.
- FMT: Fecal microbiota transplantation—transferring processed stool from a healthy donor to reset gut microbiota.
- Open-label: Everyone knows which treatment is given (higher bias risk). Double-blind RCT: neither families nor researchers know who gets the active treatment (lower bias).
- Effect symbols: Improved = better scores/less risk; Null = no clear change; Mixed = conflicting results across studies.
- IL-1β: A pro-inflammatory cytokine; higher levels may predict better response to Vitamin D/omega-3 in one trial.
- GI: Gastrointestinal (gut) symptoms such as constipation, diarrhea, abdominal pain.
- Observational: Studies that observe (do not assign) exposures; can show links but not firm causation.
Bottom line for practice:
- The clearest clinical signal so far is for folinic acid (especially with folate-receptor auto-antibodies) and for probiotics to ease GI symptoms.
- Vitamin D (± omega-3) may help behavioral subdomains (e.g., irritability), but effects on core social symptoms are inconsistent.
- Many autistic children show nutrient inadequacies (notably vitamin D/E, calcium, sometimes vitamin A/Bs) and dietary excesses when supplements are heavy—individual dietary assessment and lab monitoring matter.
- Microbiome-targeted approaches (prebiotics/FMT) are promising but preliminary.
- Specialized diets (GFCF/ketogenic) should be individualized, monitored for nutritional risks, and considered when there are clear clinical indications (e.g., epilepsy, documented intolerances).
References
Adams, J. B., Audhya, T., Geis, E., Gehn, E., Fimbres, V., Pollard, E. L., … Quig, D. W. (2018). Comprehensive nutritional and dietary intervention for autism spectrum disorder—A randomized, controlled 12-month trial. Nutrients, 10(3), 369. https://doi.org/10.3390/nu10030369
Adams, J. B., Audhya, T., McDonough-Means, S., Rubin, R. A., Quig, D., Geis, E., … Lee, W. (2011). Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatrics, 11, 111. https://doi.org/10.1186/1471-2431-11-111
Adams, J. B., Johansen, L. J., Powell, L. D., Quig, D., & Rubin, R. A. (2011). Gastrointestinal flora and gastrointestinal status in children with autism—comparisons to typical children and correlation with autism severity. BMC Gastroenterology, 11(1), 22. https://doi.org/10.1186/1471-230X-11-22
Adams, J. B., Kirby, J., Audhya, T., Whiteley, P., & Bain, J. (2022). Vitamin/mineral/micronutrient supplement for autism spectrum disorders: A research survey. BMC Pediatrics, 22, 590. https://doi.org/10.1186/s12887-022-03628-0
Al-Farsi, Y. M., Waly, M. I., Deth, R. C., Al-Sharbati, M. M., Al-Shafaee, M., Al-Farsi, O., … Ouhtit, A. (2013). Impact of nutrition on serum levels of docosahexaenoic acid among Omani children with autism. Nutrition, 29(9), 1142–1146. https://doi.org/10.1016/j.nut.2013.03.009
Alookaran, J., Liu, Y., Auchtung, T. A., Tahanan, A., Hessabi, M., Asgarisabet, P., … Rhoads, J. M. (2022). Fungi: Friend or foe? A mycobiome evaluation in children with autism and gastrointestinal symptoms. Journal of Pediatric Gastroenterology and Nutrition, 74(3), 377–382. https://doi.org/10.1097/MPG.0000000000003349
Amminger, G. P., Berger, G. E., Schaefer, M. R., Klier, C., Friedrich, M. H., & Feucht, M. (2007). Omega-3 fatty acids supplementation in children with autism: A double-blind randomized, placebo-controlled pilot study. Biological Psychiatry, 61(4), 551–553. https://doi.org/10.1016/j.biopsych.2006.05.007
Arija, V., Esteban-Figuerola, P., Morales-Hidalgo, P., Jardi, C., & Canals-Sans, J. (2023). Nutrient intake and adequacy in children with autism spectrum disorder: EPINED epidemiological study. Autism, 27(2), 371–388. https://doi.org/10.1177/13623613221098237
Arnold, L. E., Luna, R. A., Williams, K., Chan, J., Parker, R. A., Wu, Q., … Savidge, T. (2019). Probiotics for gastrointestinal symptoms and quality of life in autism: A placebo-controlled pilot trial. Journal of Child and Adolescent Psychopharmacology, 29(9), 659–669. https://doi.org/10.1089/cap.2018.0156
Barnhill, K., Gutierrez, A., Ghossainy, M., Marediya, Z., Devlin, M., Sachdev, P., … Hewitson, L. (2018). Dietary status and nutrient intake of children with autism spectrum disorder: A case-control study. Research in Autism Spectrum Disorders, 50, 51–59. https://doi.org/10.1016/j.rasd.2018.03.002
Brieger, K. K., Bakulski, K. M., Pearce, C. L., Baylin, A., Dou, J. F., Feinberg, J. I., … Schmidt, R. J. (2022). Prenatal vitamins and folic acid in a high-risk sibling cohort. Journal of Autism and Developmental Disorders, 52(6), 2801–2811. https://doi.org/10.1007/s10803-021-05110-9
Cheng, B., Zhu, J., Yang, T., Guo, M., Lai, X., Li, Q., … Li, T.-Y. (2021). Vitamin A deficiency increases the risk of gastrointestinal comorbidity and exacerbates core symptoms in children with autism spectrum disorder. Pediatric Research, 89(1), 211–216. https://doi.org/10.1038/s41390-020-0865-y
Doenyas, C. (2018). Dietary interventions for autism spectrum disorder: New perspectives from the gut–brain axis. Physiology & Behavior, 194, 577–582. https://doi.org/10.1016/j.physbeh.2018.07.014
Feng, J., et al. (2023). Zinc/copper balance in children with autism spectrum disorder. Nutrients, 15(3), 512. https://doi.org/10.3390/nu15030512
Gaougaou, G., Zahra, R., Morel, S., Bélanger, V., Knoth, I. S., Cousineau, D., … Marcil, V. (2025). Acceptability and safety of a probiotic beverage in children with autism spectrum disorder. Journal of Neurodevelopmental Disorders, 17, 30. https://doi.org/10.1186/s11689-025-09617-5
Gogou, M., & Kolios, G. (2020). Nutritional supplements during gestation and autism spectrum disorder: What do we really know? Journal of the American College of Nutrition, 39(3), 261–271. https://doi.org/10.1080/07315724.2019.1635920
Grimaldi, R., Gibson, G. R., Vulevic, J., Giallourou, N., Castro-Mejia, J. L., Hansen, L. H., … & Costabile, A. (2018). A prebiotic intervention study in children with autism spectrum disorders (ASDs). Microbiome, 6(1), 133. https://doi.org/10.1186/s40168-018-0523-3
Guo, M., Zhu, J., Yang, T., Lai, X., Liu, X., Liu, J., … Li, T. (2018). Vitamin A improves the symptoms of autism spectrum disorders and decreases 5-HT: A pilot study. Brain Research Bulletin, 137, 35–40. https://doi.org/10.1016/j.brainresbull.2017.11.001
Kaluzna-Czaplinska, J., & Jozwik-Pruska, J. (2016). Nutritional strategies and personalized diet in autism—Choice or necessity? Trends in Food Science & Technology, 49, 45–50. https://doi.org/10.1016/j.tifs.2016.01.005
Kaluzna-Czaplinska, J., Socha, E., & Rynkowski, J. (2011). B-vitamin supplementation reduces excretion of urinary dicarboxylic acids in autistic children. Nutrition Research, 31(7), 497–502. https://doi.org/10.1016/j.nutres.2011.06.002
Kerley, C. P., Power, C., Gallagher, L., & Coghlan, D. (2017). Lack of effect of vitamin D3 supplementation in autism: A 20-week, placebo-controlled RCT. Archives of Disease in Childhood, 102(11), 1030–1036. https://doi.org/10.1136/archdischild-2017-312783
Kittana, M., Ahmadani, A., Stojanovska, L., & Attlee, A. (2022). The role of vitamin D supplementation in children with ASD: A narrative review. Nutrients, 14(1), 26. https://doi.org/10.3390/nu14010026
Krakowiak, P., Walker, C. K., Bremer, A. A., Baker, A. S., Ozonoff, S., Hansen, R. L., & Hertz-Picciotto, I. (2012). Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics, 129(5), e1121–e1128. https://doi.org/10.1542/peds.2011-2583
Lasheras, I., Real-López, M., & Santabárbara, J. (2023). Prevalence of gastrointestinal symptoms in ASD: A meta-analysis. Anales de Pediatría, 99(2), 102–110. https://doi.org/10.1016/j.anpedi.2023.05.011
Levy, S. E., & Hyman, S. L. (2015). Complementary and alternative medicine treatments for children with ASD. Child and Adolescent Psychiatric Clinics of North America, 24(1), 117–+. https://doi.org/10.1016/j.chc.2014.09.004
Li, N., Chen, H., Cheng, Y., Xu, F., Ruan, G., Ying, S., … & Wei, Y. (2021). Fecal microbiota transplantation relieves gastrointestinal and autism symptoms by improving the gut microbiota in an open-label study. Frontiers in Cellular and Infection Microbiology, 11, 759435. https://doi.org/10.3389/fcimb.2021.759435
Liew, Z., Ritz, B., Virk, J., & Olsen, J. (2016). Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: A Danish National Birth Cohort study. Autism Research, 9(9), 951–958. https://doi.org/10.1002/aur.1591
Liu, J., Liu, X., Xiong, X.-Q., Yang, T., Cui, T., Hou, N.-L., … Li, T.-Y. (2017). Effect of vitamin A supplementation on gut microbiota in children with ASD—A pilot study. BMC Microbiology, 17, 204. https://doi.org/10.1186/s12866-017-1096-1
Mazahery, H., Conlon, C. A., Beck, K. L., Mugridge, O., Kruger, M. C., Stonehouse, W., … von Hurst, P. R. (2019a). A randomized controlled trial of vitamin D and omega-3 LCPUFA in irritability and hyperactivity among children with ASD. Journal of Steroid Biochemistry and Molecular Biology, 187, 9–16. https://doi.org/10.1016/j.jsbmb.2018.10.017
Mazahery, H., Conlon, C. A., Beck, K. L., Mugridge, O., Kruger, M. C., Stonehouse, W., … von Hurst, P. R. (2019b). Vitamin D and omega-3 LCPUFA for core symptoms of ASD—RCT. Journal of Autism and Developmental Disorders, 49(5), 1778–1794. https://doi.org/10.1007/s10803-018-3860-y
Mazahery, H., Conlon, C., Beck, K., Kruger, M., Stonehouse, W., Camargo, C., … von Hurst, P. (2020). Inflammation (IL-1β) modifies Vitamin D/omega-3 effects on ASD symptoms. Nutrients, 12(3), 661. https://doi.org/10.3390/nu12030661
Panda, P. K., Sharawat, I. K., Saha, S., Gupta, D., Palayullakandi, A., & Meena, K. (2024). Efficacy of oral folinic acid supplementation in children with ASD: A randomized double-blind, placebo-controlled trial. European Journal of Pediatrics, 183(11), 4827–4835. https://doi.org/10.1007/s00431-024-05762-6
Panda, S., Shukla, A., et al. (2024). Folinic acid supplementation in autism spectrum disorder: Clinical outcomes and biomarker changes. Journal of Autism and Developmental Disorders.
Peretti, S., Mariano, M., Mazzocchetti, C., Mazza, M., Pino, M. C., & Valenti, M. (2019). Diet: The keystone of autism spectrum disorder? Nutritional Neuroscience, 22(12), 825–839. https://doi.org/10.1080/1028415X.2018.1464819
Raghavan, R., Riley, A. W., Volk, H., Caruso, D., Hironaka, L., Sices, L., … Wang, X. (2018). Maternal multivitamin intake, plasma folate and B12, and ASD risk. Paediatric and Perinatal Epidemiology, 32(1), 100–111. https://doi.org/10.1111/ppe.12414
Ruskin, D. N., Fortin, J. A., Bisnauth, S. N., & Masino, S. A. (2017). Ketogenic diets improve behaviors associated with ASD in EL mice. Physiology & Behavior, 168, 138–145. https://doi.org/10.1016/j.physbeh.2016.10.023
Shaaban, S. Y., El Gendy, Y. G., Mehanna, N. S., El-Senousy, W. M., El-Feki, H. S. A., Saad, K., & El-Asheer, O. M. (2018). Probiotics in children with ASD: A prospective, open-label study. Nutritional Neuroscience, 21(9), 676–681. https://doi.org/10.1080/1028415X.2017.1347746
Song, L., Luo, X., Jiang, Q., Chen, Z., Zhou, L., Wang, D., & Chen, A. (2020). Vitamin D supplementation is beneficial for children with ASD: A meta-analysis. Clinical Psychopharmacology and Neuroscience, 18(2), 203–213. https://doi.org/10.9758/cpn.2020.18.2.203
Stewart, P. A., Hyman, S. L., Schmidt, B. L., Macklin, E. A., Reynolds, A., Johnson, C. R., … & Manning-Courtney, P. (2015). Dietary supplementation in children with autism spectrum disorders: Common, insufficient, and excessive. Journal of the Academy of Nutrition and Dietetics, 115(8), 1237–1248. https://doi.org/10.1016/j.jand.2015.03.026
Surén, P., Roth, C., Bresnahan, M., Haugen, M., Hornig, M., Hirtz, D., … Stoltenberg, C. (2013). Maternal folic acid supplements and risk of autistic disorder. JAMA, 309(6), 570–577. https://doi.org/10.1001/jama.2012.155925
Tomova, A., Soltys, K., Kemenyova, P., Karhanek, M., & Babinska, K. (2020). The influence of food intake specificity in children with autism on gut microbiota. International Journal of Molecular Sciences, 21(8), 2797. https://doi.org/10.3390/ijms21082797
Voigt, R. G., Mellon, M. W., Katusic, S. K., Weaver, A. L., Matern, D., Mellon, B., … & Barbaresi, W. J. (2014). Dietary docosahexaenoic acid supplementation in children with autism. Journal of Pediatric Gastroenterology and Nutrition, 58(6), 715–722. https://doi.org/10.1097/MPG.0000000000000260
Yang, T., Chen, L., Dai, Y., Jia, F., Hao, Y., Li, L., … Li, T. (2022). Vitamin A status is more commonly associated with symptoms and neurodevelopment in boys with ASD—A multicenter study. Frontiers in Nutrition, 9, 851980. https://doi.org/10.3389/fnut.2022.851980
Zeng, P., Zhang, C., Fan, Z., Yang, C., Cai, W., Huang, Y., … Yang, J. (2024). Effect of probiotics on children with ASD: A meta-analysis. Italian Journal of Pediatrics, 50(1), 120. https://doi.org/10.1186/s13052-024-01692-z
Zhang, L., Xu, Y., Li, H., Li, B., Duan, G., & Zhu, C. (2022). Probiotics in children with ASD: Study protocol for an RCT. PLOS ONE, 17(2), e0263109. https://doi.org/10.1371/journal.pone.0263109
Zhu, J., Hua, X., Yang, T., Guo, M., Li, Q., Xiao, L., … Li, T. (2022). Alterations in gut vitamin and amino-acid metabolism are associated with symptoms and neurodevelopment in ASD. Journal of Autism and Developmental Disorders, 52(7), 3116–3128. https://doi.org/10.1007/s10803-021-05066-w